Acute lymphoblastic leukaemia trials in Saudi Arabia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 4Taking people
  Asciminib Roll-over Study

  Where

  Riyadh

  Age

  7 years to 100 years

  People

  347 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT04877522 · EU 2023-507557-16-00
• Phase 3Taking people
  Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia

  Where

  Jeddah, Riyadh

  Age

  1 day to 1 year

  People

  160 worldwide

  Run by

  Princess Maxima Center for Pediatric Oncology

  See details and how to joinNCT05327894 · EU 2022-502503-30-00
• Phase 2/3Taking people
  Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

  Where

  Riyadh

  Age

  1 month to 18 years

  People

  1,800 worldwide

  Run by

  St. Anna Kinderkrebsforschung

  See details and how to joinNCT01949129 · EU 2024-512657-24-00
• Phase 1Taking people
  CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia

  Where

  Riyadh

  Age

  18 years to 75 years

  People

  24

  Run by

  King Faisal Specialist Hospital & Research Center

  See details and how to joinNCT07361029
• Phase 3Taking people
  Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

  Where

  Riyadh

  Age

  14 years to 65 years

  People

  264

  Run by

  King Faisal Specialist Hospital & Research Center

  See details and how to joinNCT04314219